Boehringer Ingelheim, Eurofins Medigenomix partner in DNA banking and pharmacogenetics, pharmacogenomics

NewsGuard 100/100 Score

Boehringer Ingelheim Pharma GmbH & Co. KG, an international research-driven pharma company, and Eurofins Medigenomix GmbH, a competence center for genetic analyses of the Eurofins Scientific Group, concluded a long-term service agreement in the area of DNA banking, as well as a master service agreement for pharmacogenetic and pharmacogenomic services. For DNA banking Eurofins Medigenomix is supporting operations of Boehringer Ingelheim's central DNA bank at Biberach an der Riss.

Within the scope of clinical phase I-IV studies, which Boehringer Ingelheim is conducting worldwide in its different therapy areas, blood samples are collected for DNA banking purposes. On behalf of Boehringer Ingelheim many thousands of blood samples per year will be processed at Eurofins Medigenomix using a fully automated robot-based system: In this automated process genomic DNA is extracted from blood samples. DNA samples then are normalized and aliquoted into plates. Subsequently, plates with DNA samples are shipped back from Eurofins Medigenomix to Boehringer Ingelheim. Upon receipt at Biberach DNA samples will be stored frozen in the fully automated DNA bank with a storage capacity of several millions of samples. In the area of pharmacogenetics / pharmacogenomics Eurofins Medigenomix will support

Boehringer Ingelheim's Pharmacogenomics Unit in analyses of stored samples from the central DNA bank, e.g. in genotyping, as well as in analyses which shall be performed in the scope of clinical studies. Both services, later analyses of stored DNA samples and parallel analyses of samples coming from global clinical trials, support Boehringer Ingelheim's research and development activities and make a contribution to the development of effective and safe drugs.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baylor study reveals role of newly inherited DNA variants in recessive diseases